Campylobacter fetus bacteremia in a patient with adult T cell leukemia [2]

Clinical Infectious Diseases

Volumn 36, Issue 11, 2003, Pages 1497-1498

  Chuman, Yoshiko ^a,b   Takata, Tohru ^c   Sameshima, Hisako ^a   Takeuchi, Shogo ^a   Takatsuka, Yoshifusa ^a   Makino, Torahiko ^a   Blaser, Martin J ^d   Utsunomiya, Atae ^a  

^a IMAMURA BUN IN HOSPITAL   (Japan)

^b Nanpuh Hospital   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; SULPERAZON; VINCRISTINE;

AGED; BACTEREMIA; BACTERIAL STRAIN; CAMPYLOBACTER FETUS; CANCER REGRESSION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; SKIN MANIFESTATION; SPLENOMEGALY; T CELL LEUKEMIA; TREATMENT OUTCOME;

AGED; BACTEREMIA; CAMPYLOBACTER FETUS; CAMPYLOBACTER INFECTIONS; FEMALE; HUMANS; LEUKEMIA, T-CELL; OPPORTUNISTIC INFECTIONS;

EID: 0038468727     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374874     Document Type: Letter

References (11)

1. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79:428-37.
2. White JD, Zaknoen SL, Kasten-Sportes C, et al. Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma. Cancer 1995; 75:1598-607.
3. Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 2001; 97:3177-83.
4. Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells. Jpn J Cancer Res 1987; 78:639-42.
5. Penner JL. The genus Campylobacter: a decade of progress. Clin Microbiol Rev 1988; 1:157-72.
6. Costel EE, Wheeler AP, Gregg CR. Campylobacter fetus ssp. fetus cholecystitis and relapsing bacteremia in a patient with acquired immunodeficiency syndrome. Southern Med Journal 1984; 77:927-8.
7. Rao GG, Karim QN, Maddocks A, Hillman RJ, Harris JR, Pinching AJ. Campylobacter fetus infections in two patients with AIDS. J Infect 1990; 20:170-2.
8. Meier PA, Dooley DP, Jorgensen JH, Sanders CC, Huang WM, Patterson JE. Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus-infected patients. J Infect Dis 1998; 177:951-4.
9. Blaser MJ. Campylobacter fetus: emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis 1998; 27:256-8.
10. Pei Z, Ellison RT, Lewis RV, Blaser MJ. Purification and characterization of a family of high molecular weight surface-array proteins from Campylobacter fetus. J Biol Chem 1988; 263:6416-20.
11. Blaser MJ, Smith PA, Repine JE, Joiner KA. Pathogenesis of Campylobacter fetus infection: failure to bind C3b explains serum and phagocytosis resistance. J Clin Invest 1988; 81:1434-44.